Recherche avancée
Affichage des résultats 8101 à 8120 sur 8564 au total
-
Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug
N. Eymard, N. Bessonov, V. Volpert, P. Kurbatova, F. Gueyffier, P. Nony
-
Projet Rebuild the Evidence Base
Hélène Vaillant-Roussel, Clara Blanchard, Thibault Menini, Elodie Charuel, Bruno Pereira, Florian Naudet, Behrouz Kassai Koupai, Guillaume Grenet, François Gueyffier, Michel Cucherat, Rémy Boussageon
-
Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis
G. Grenet, H. H. Le, T. Bejan-Angoulvant, S. Erpeldinger, R. Boussageon, B. Kassai, P. Moulin, F. Gueyffier, M. Cucherat
-
GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis
G. Grenet, S. Ribault, G. B. Nguyen, F. Glais, A. Metge, T. Linet, B. Kassai-Koupai, C. Cornu, T. Bejan-Angoulvant, S. Erpeldinger, R. Boussageon, A. Gouraud, F. Bonnet, M. Cucherat, P. Moulin, F. Gueyffier
-
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
S. Erpeldinger, M. B. Rehman, C. Berkhout, C. Pigache, Y. Zerbib, F. Regnault, E. Guerin, I. Supper, Catherine Cornu, B. Kassai, F. Gueyffier, R. Boussageon
-
Can we identify response markers to antihypertensive drugs? First results from the Ideal Trial
F. Gueyffier, F. Subtil, T. Bejan-Angoulvant, Y. Zerbib, J. P. Baguet, J. M. Boivin, A. Mercier, G. Leftheriotis, J. P. Gagnol, J. P. Fauvel, C. Giraud, G. Bricca, Delphine Maucort-Boulch, S. Erpeldinger
-
Different treatment benefits were estimated by clinical trials performed in adults compared with those performed in children
Perrine Janiaud, A. Lajoinie, F. Cour-Andlauer, Catherine Cornu, P. Cochat, Michel Cucherat, F. Gueyffier, B. Kassai
-
The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
Laurence Lion-François, François Gueyffier, Catherine Mercier, Daniel Gérard, Vania Herbillon, Isabelle Kemlin, Diana Rodriguez, Tiphanie Ginhoux, Emeline Peyric, Virginie Coutinho, Valentine Bréant, Vincent Des Portes, Stéphane Pinson, Patrick Combemale, Behrouz Kassai
-
Essais cliniques institutionnels : quel monitoring ?
C. Cornu, C. Binquet, C. Thalamas, C. Vigouroux, S. Gaillard, T. Ginhoux, B. Vaz, C. Jossan, A. Félin, A. Sailly, François Gueyffier, V. Journot, Behrouz Kassai
-
Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review
Rémy Boussageon, Irène Supper, Sylvie Erpeldinger, Michel Cucherat, Theodora Bejan-Angoulvant, Behrouz Kassai, Catherine Cornu, François Gueyffier
-
L\textquoterighteffet placebo chez l\textquoterightenfant est méconnu et peu étudié
B. Kassai, H. Gheit, R. Boussageon, F. Gueyffier
-
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.
Rémy Boussageon, Irène Supper, Theodora Bejan-Angoulvant, Nadir Kellou, Michel Cucherat, Jean-Pierre Boissel, Behrouz Kassai, Moreau Alain, François Gueyffier, Catherine Cornu
-
Effect of intensive glucose lowering treatment on all cause mortality cardiovascular death and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
R. Boussageon, T. Bejan-Angoulvant, M. Saadatian-Elahi, S. Lafont, C. Bergeonneau, Behrouz Kassai, S. Erpeldinger, Jm. Wright, François Gueyffier, Catherine Cornu
-
SCORE should be preferred to Framingham to predict cardiovascular death in French population
I. Marchant, J-P. Boissel, Behrouz Kassai, T. Bejan-Angoulvant, J. Massol, C. Vidal, E. Amsallem, F. Naudin, P. Galan, S. Czernichow, Patrice Nony, François Gueyffier
-
Recueil systématique et actif des evènements indésirables médicamenteux chez les enfants admis aux urgences pédiatriques
F. Planchamp, K.-A. Nguyen, T. Vial, S. Nasri, E. Javouhey, Y. Gillet, B. Ranchin, F. Villard, D. Floret, P. Cochat, François Gueyffier, Behrouz Kassai
-
Severe myoclonic epilepsy in infancy: A systematic review and a meta-analysis of individual patient data
Behrouz Kassai, C. Chiron, S. Augier, Michel Cucherat, E. Rey, François Gueyffier, R. Guerrini, J. Vincent, O. Dulac, Gérard Pons
-
Critères intermédiaires et critères de substitution
Behrouz Kassai, François Gueyffier, J-P. Boissel
-
Safety of computerized drug management: a case report
K.-A. Nguyen, T. Vial, François Gueyffier, S. Marignier, P. Cochat, Behrouz Kassai
-
The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests
Behrouz Kassai, N.R. Shah, A. Leizorovicz, Michel Cucherat, François Gueyffier, J.-P. Boissel
-
Absolute benefit number needed to treat and gain in life expectancy: which efficacy indices for measuring the treatment benefit?
Behrouz Kassai, François Gueyffier, J.-P. Boissel, F. Boutitie, Michel Cucherat